Results 61 to 70 of about 2,537 (171)

A Qualitative Review of Patient Feedback for the OPAT (Outpatient Antimicrobial Therapy) Service in Bristol

Antibiotics
Outpatient parenteral antimicrobial therapy (OPAT) aims to deliver intravenous antimicrobials to medically stable patients with complex infections outside of a hospital setting. There is good evidence to demonstrate the safety and efficacy of OPAT in the
Shuchita Soni, Irasha Harding, Carys Jones, Sue Wade, Jenna Norton, Jennifer Siobhan Pollock   +5 more
doaj   +1 more source

Zoonotic Streptococcus canis Bacteremia Following a Dog Scratch in an Elderly Patient With a Nonconditional Pacemaker

Case Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
Streptococcus canis is a β‐hemolytic Group G streptococcus commonly found in the microbiome of dogs and cats and is an uncommon cause of invasive human infection. Although typically regarded as a veterinary pathogen, S. canis has been reported to cause bacteremia, endocarditis, and other severe infections in humans, particularly in older adults with ...
Kamel Alachraf, Patrick Trouten, Jessica Thayer, Larry M. Bush   +3 more
wiley   +1 more source

Outpatient parenteral ­antimicrobial therapy (OPAT) and the general ­physician [PDF]

Clinical Medicine, 2013
Outpatient parenteral antimicrobial therapy (OPAT) refers to outpatient or community-based management of an infection via the administration of an intravenous (IV) antimicrobial without an overnight hospital stay. Patients may be managed without admission or may transition to OPAT following hospitalisation.
Gavin Barlow, DA Barr, RA Seaton
openaire   +2 more sources

A Review of β‐Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications

International Journal of Microbiology, Volume 2026, Issue 1, 2026.
β‐Lactam antibiotics have long served as a cornerstone for treating bacterial infections. However, their widespread and often indiscriminate use has fueled the emergence of multidrug‐resistant Gram‐negative pathogens, primarily through the production and dissemination of β‐lactamase enzymes.
Mohammad Javad Roustaye Gourabi, Anita Nikoo, Bita Khanbabaei, Masoud Kargar, Amirhossein Fayyazi, Seyyed Mohammad Javad Mousavi, Amirhossein Aghdaee, Ali Hashemi, Javad Yasbolaghi Sharahi, Swaran J. S. Flora   +9 more
wiley   +1 more source

Provider Experience with Outpatient Parenteral Antimicrobial Therapy in Veterans Affairs Healthcare Systems: a qualitative study

Antimicrobial Stewardship & Healthcare Epidemiology
Background: Variability in outpatient parenteral antimicrobial therapy (OPAT) management and challenges to providing recommended OPAT care can compromise patient safety and care quality. Little is known about how OPAT is currently delivered by healthcare
Elizabeth Scruggs-Wodkowski, Lauren Gauntlett, Amanda Blok, Danielle Helminski, Nicholas Henry, Sara Keller, Ronald Kendall, Manon Nitta, Allison Ranusch, Molly Harrod, Sarah Krein   +10 more
doaj   +1 more source

Abstract Supplement

Pulmonary Medicine, Volume 2026, Issue 1, 2026.
 
Marzia Folegani, Semonti Nandi
wiley   +1 more source

Qualitative analysis of barriers and facilitators to healthcare engagement for people with injecting‐related invasive infections using a social ecological framework

Addiction, Volume 120, Issue 12, Page 2476-2488, December 2025.
Abstract Background and aims Injecting‐related bacterial infections are increasing in many countries. Systemic infections often require prolonged treatment. Evidence suggests that people who inject drugs who have invasive infections are less likely to complete antimicrobial treatment and have poorer outcomes than patients without a history of injecting
Lucy O. Attwood, Sophia E. Schroeder, Olga Vujovic, Andrew J. Stewardson, Joseph S. Doyle, Paul Dietze, Peter Higgs, Samantha Colledge‐Frisby   +7 more
wiley   +1 more source

Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidence

Journal of Infection and Public Health
Outpatient parenteral antimicrobial therapy (OPAT) program has become an established clinical practice globally, though its implementation varies across jurisdictions. This review explores the implementation of OPAT within contemporary healthcare systems.
Solomon Ahmed Mohammed, Natasha Roberts, David Nicolás, Sean Unwin, Menino Cotta, Jason A. Roberts, Fekade B. Sime   +6 more
doaj   +1 more source

Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States

Mycoses, Volume 68, Issue 9, September 2025.
ABSTRACT Background Rezafungin, a novel echinocandin with once‐weekly intravenous dosing, offers potential advantages for outpatient parenteral antifungal therapy (OPAT) in invasive candidiasis (IC). While clinical trial data support its efficacy and safety, real‐world experience remains limited.
Ilana Reinhold, Giovanni Mori, Massimiliano Lanzafame, Alessandro Limongelli, Antonio Vena, Julia Götz, Stilla Bauernfeind, Frank Hanses, Lukas Tometten, Michael Mayer, Ansgar Rieke, Ana Soriano‐Martin, Maricela Valerio, Jose A. Vazquez, Patrick Yue, Laman Rahimli, Nijat Azimli, Ertan Sal, Jon Salmanton‐García, Natalia Vasenda, Rosanne Sprute, Jannik Stemler, Sebastian Wingen‐Heimann, Oliver A. Cornely, Danila Seidel   +24 more
wiley   +1 more source

Kinetically Limited Growth of Dendritic Tin Oxide Thin Films: a Machine Learning Study beyond the Structure Zone Diagram

Advanced Science, Volume 12, Issue 32, August 28, 2025.
This work presents a critical evaluation of the empirical Thornton's structure zone diagram, a cornerstone in predicting thin film microstructure. Through transmission electron microscopy, we observe that Sn─O thin films form nanosized dendrites, which are not expected according to the structure zone diagram.
Denis Music, Xuelian Xiao, Rami Naser, Keke Chang, Grzegorz Sadowski, Pär A. T. Olsson   +5 more
wiley   +1 more source